News & Events Press Releases Events & Presentations Year None201920182017 01.22 2019 Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency 01.03 2019 Translate Bio Appoints Robert Meyer, MD, to its Board of Directors 01.03 2019 Translate Bio Advances Programs in Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency Upcoming Events 02.27 2019 8th Annual Leerink Partners Global Healthcare Conference Past Events 12.05 2018 Citi Global Healthcare Conference 11.29 2018 Evercore ISI Healthcare Conference 11.14 2018 Stifel 2018 Healthcare Conference 11.11 2018 6th International mRNA Health Conference 10.17 2018 North American Cystic Fibrosis Conference 10.06 2018 Cystic Fibrosis Foundation’s CF Cycle for Life 10.01 2018 Leerink Partners Rare Disease & Immuno-Oncology Roundtable 09.04 2018 Citi’s 13th Annual Biotech Conference 06.06 2018 41st Annual European Cystic Fibrosis Conference 06.04 2018 BIO International Convention Pagination Current page 1 Page 2 Next page next › Last page last »
